FDA Clearance Tracker · P990009-S039
FLOSEAL HEMOSTATIC MATRIX
Last checked: Nov 20, 2026Latest source record: Feb 26, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Feb 26, 2015
Approved
Time to decision
216 days
Received Jul 25, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P990009-S039
- Device name
- FLOSEAL HEMOSTATIC MATRIX
- Applicant
- Baxter Healthcare Corp
- Applicant location
- Round Lake, IL
- Received
- Jul 25, 2014
- Decided
- Feb 26, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P990009
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT BAXTER HEALTHCARE CORPORATION IN CLEVELAND, MISSOURI.
Source documents
Other decisions for Baxter Healthcare Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Helion Viewer Suite510(k)
K254265 · Decided May 27, 2026 · 148 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.